FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 317:1688-1691 December 31, 1987 Number 27 Next

	Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

Abstract

We used very sensitive and specific monoclonal-antibody sandwich assays for human chorionic gonadotropin (hCG) and human luteinizing hormone (hLH) to measure both hormones in serum samples from normal men and women. When single serum samples from 92 men were studied, 73 percent had detectable hCG. In normal men, the amount of detectable hCG averaged 8.9 pg per milliliter, with a range of less than 3.0 to 160 pg per milliliter (biologic potency = 13,450 IU per milligram). In postmenopausal women the hCG level averaged 111 pg per milliliter and ranged from 32 to 510. In women of reproductive age the hCG level varied with the menstrual cycle. Gonadotropin-releasing hormone administered to 10 normal men increased both hCG and hLH. When daily serum samples were studied throughout a normal menstrual cycle, hCG concentrations paralleled those of hLH; follicular-phase concentrations were higher than those of the luteal phase, and there was a midcycle ovulatory peak of hCG coincident with the hLH peak. When hCG was measured every 10 minutes for six hours in eight postmenopausal women, distinct pulses were detected in parallel with those of hLH: hLH pulsed at a mean (+/- SEM) frequency of 0.56 +/- 0.08 pulses per hour; hCG pulsed at 0.54 +/- 0.07 pulses per hour. The mean pulse durations were 89 +/- 22 and 56 +/- 20 minutes for hLH and hCG, respectively. We conclude that hCG is produced in a pulsatile fashion, probably by the pituitary, in all normal adults.

Source Information

Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City 84132.

This article has been cited by other articles:

• de Medeiros, S.F., Norman, R.J. (2009). Human choriogonadotrophin protein core and sugar branches heterogeneity: basic and clinical insights. Hum Reprod Update 15: 69-95 [Abstract] [Full Text]  
• Veldhuis, J. D., Keenan, D. M., Pincus, S. M. (2008). Motivations and Methods for Analyzing Pulsatile Hormone Secretion. Endocr. Rev. 29: 823-864 [Abstract] [Full Text]  
• Stenman, U.-H., Tiitinen, A., Alfthan, H., Valmu, L. (2006). The classification, functions and clinical use of different isoforms of HCG. Hum Reprod Update 12: 769-784 [Abstract] [Full Text]  
• Cole, L. A. (2005). "Background" Human Chorionic Gonadotropin in Healthy, Nonpregnant Women. Clin. Chem. 51: 1765-1766 [Full Text]  
• Snyder, J. A., Haymond, S., Parvin, C. A., Gronowski, A. M., Grenache, D. G. (2005). Diagnostic Considerations in the Measurement of Human Chorionic Gonadotropin in Aging Women. Clin. Chem. 51: 1830-1835 [Abstract] [Full Text]  
• chen, J., Qiu, Q., Lohstroh, P. N., Overstreet, J. W., Lasley, B. L. (2003). Hormonal Characteristics in the Early Luteal Phase of Conceptive and Nonconceptive Menstrual Cycles. Reproductive Sciences 10: 27-31 [Abstract]  
• Couzinet, B., Pantel, J., Chanson, P., Young, J., Brailly, S., Huhtaniemi, I. T., Bidart, J.-M., Schaison, G. (2000). Measurement of Plasma Free Luteinizing Hormone {beta}-Subunit in Women. J. Clin. Endocrinol. Metab. 85: 2293-2298 [Abstract] [Full Text]  
• Stenman, U.-H., Unkila-Kallio, L., Korhonen, J., Alfthan, H. (1997). Immunoprocedures for detecting human chorionic gonadotropin: clinical aspects and doping control. Clin. Chem. 43: 1293-1298 [Abstract] [Full Text]